Manulife (Manufacturers Life Insurance)
APLT

Manulife (Manufacturers Life Insurance)’s Applied Therapeutics APLT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-123,725
Closed -$1.05M – 2973
2024
Q3 		$1.05M Buy
123,725
+86,901
+236% +$512K ﹤0.01% 1899
2024
Q2 		$172K Buy
+36,824
New +$174K ﹤0.01% 2662
2022
Q1 		– Sell
-11,189
Closed -$100 – 3075
2021
Q4 		$100 Buy
11,189
+266
+2% +$3.49K ﹤0.01% 3048
2021
Q3 		$181K Sell
10,923
-267
-2% -$4.61K ﹤0.01% 3017
2021
Q2 		$233K Buy
11,190
+1,081
+11% +$20.5K ﹤0.01% 2998
2021
Q1 		$190K Buy
+10,109
New +$218K ﹤0.01% 2909
2020
Q3 		– Sell
-8,169
Closed -$291K – 2903
2020
Q2 		$291K Buy
+8,169
New +$342K ﹤0.01% 2277

Other funds holding APLT

VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s APLT Position: Q4 2024 in Review

Manulife (Manufacturers Life Insurance) sold out of Applied Therapeutics (APLT) in Q4 2024, closing a stake of 123,725 shares — an estimated $1.05M sold.

Manulife (Manufacturers Life Insurance) first reported a position in APLT in Q2 2020 and held it in 7 quarters. The position peaked at $1.05M in Q3 2024. 119 funds tracked by Wall St. Rank hold APLT as of Q4 2024.

  • Manulife (Manufacturers Life Insurance) reported no remaining Applied Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 123,725 Applied Therapeutics shares in Q4 2024, an estimated $1.05M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Applied Therapeutics in Q2 2020 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Applied Therapeutics position peaked at $1.05M in Q3 2024.
  • 119 funds tracked by Wall St. Rank held Applied Therapeutics as of Q4 2024.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2024, filed 14 Feb 2025.